Archive for category: COVID-19

The DoH are seeking EOI from eligible practices who wish to participate in an expanded COVAX program.
Details are here

Dr Trish Baker’s, interview with ABC about these results is here.

Preliminary results from the AGPA COVAX Capability Survey are:

• On average Practices are receiving about 230 AZ doses per week.
• On average Practices would like to deliver about 310 doses per week (x 4000 practices = 1.24 M doses per week – more than the current Australian production)
• On average Practices think they could surge to about 340 doses per week (x 4000 Practices = 1.36M per week)
• 96% of Practices think that the administrative burden of COVID vaccination is Significantly Greater (79.6%) or Greater(16.3%) when compered to influenza vaccines.
• Almost 33% of Practices remain very concerned or concerned about their medicolegal liability regarding COVAX.
• 67% of Practices think it is Difficult or Very Difficult for Patients to understand the risk vs benefit of COVID vaccination.
• The major impact of running COVID vaccination clinics has been a reduction in service in the areas of Chronic Disease Management and Health Assessments.
• 70% of Practices would be willing or very willing to deliver the Pfizer vaccine

Department of Health – Primary Health Care COVID-19 Response Teleconference 05/05/2021 – Meeting notes from Dr Maria Boulton

The Primary Care Implementation Group (PCIG) is an online meeting that includes most primary healthcare peak bodies. It is convened weekly by the Department of Health as part of the COVID-19 response.
Dr Maria Boulton attends on behalf of the AGPA.

The DoH has released updated advice on in-reach COVID-19 vaccination services for aged care workers , advice on co-administration of vaccines, updated AstraZeneca vaccine Easy Read, and updated links.

In-reach for Aged Care Workers

Phase 1B General Practice Update – 30 April

The last two months have been a busy time for the AGPA directors with media commentary regarding the COVAX rollout covering issues from  assistance with consumables and vaccine supply (or lack thereof) to medical indemnity associated with the provision of Astra Zeneca vaccine to patients under 50.